We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
76
KLA
KLAC
$275B
$354M 0.43%
8,234,480
-938,150
-10% -$36.2M
SONY icon
77
Sony
SONY
$123B
$353M 0.42%
13,954,225
-568,460
-4% -$13.5M
SNY icon
78
Sanofi
SNY
$104B
$348M 0.42%
6,943,569
+2,352,385
+51% +$116M
CTVA icon
79
Corteva
CTVA
$59.7B
$343M 0.41%
7,259,368
+678,522
+10% +$30.9M
CNQ icon
80
Canadian Natural Resources
CNQ
$96.9B
$343M 0.41%
16,019,700
-474,945
-3% -$9.61M
SAIC icon
81
Saic
SAIC
$5.03B
$342M 0.41%
4,087,603
-29,433
-0.7% -$2.56M
ATVI
82
DELISTED
Activision Blizzard
ATVI
$339M 0.41%
5,101,578
+710,104
+16% +$48.5M
CNI icon
83
Canadian National Railway
CNI
$78.3B
$338M 0.41%
2,748,500
-209,230
-7% -$26.5M
DRE
84
DELISTED
Duke Realty Corp.
DRE
$335M 0.4%
5,103,970
-36,286
-0.7% -$2.1M
NTAP icon
85
NetApp
NTAP
$32.9B
$324M 0.39%
3,516,736
-207,632
-6% -$18.7M
WAB icon
86
Wabtec
WAB
$51.1B
$316M 0.38%
3,431,419
-183,061
-5% -$16.8M
BMY icon
87
Bristol-Myers Squibb
BMY
$127B
$308M 0.37%
4,946,825
+786,945
+19% +$46.2M
SYF icon
88
Synchrony
SYF
$23.7B
$306M 0.37%
6,589,292
+80,405
+1% +$3.87M
URI icon
89
United Rentals
URI
$71.1B
$304M 0.37%
913,505
-146,543
-14% -$52.2M
RHI icon
90
Robert Half
RHI
$3.61B
$303M 0.37%
2,720,373
-345,742
-11% -$38.5M
EFOR
91
Everforth Inc
EFOR
$845M
$294M 0.35%
2,385,620
-443,297
-16% -$54.2M
VRT icon
92
Vertiv
VRT
$112B
$292M 0.35%
11,693,371
+1,674,611
+17% +$41.9M
ELV icon
93
Elevance Health
ELV
$81.9B
$291M 0.35%
627,528
-20,463
-3% -$8.61M
PH icon
94
Parker-Hannifin
PH
$125B
$290M 0.35%
911,159
-8,485
-0.9% -$2.62M
D icon
95
Dominion Energy
D
$62.5B
$289M 0.35%
3,683,246
+618,709
+20% +$46.6M
AON icon
96
Aon
AON
$77.3B
$289M 0.35%
961,718
-21,508
-2% -$6.45M
CW icon
97
Curtiss-Wright
CW
$27.7B
$288M 0.35%
2,077,283
-46,505
-2% -$6.14M
EQR icon
98
Equity Residential
EQR
$25.4B
$288M 0.35%
3,177,540
-24,089
-0.8% -$2.07M
PFE icon
99
Pfizer
PFE
$140B
$287M 0.35%
4,855,444
-8,738,563
-64% -$433M
CVE icon
100
Cenovus Energy
CVE
$54.6B
$286M 0.34%
20,566,778
+8,634,770
+72% +$103M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.